Scientific Sessions 2025  /  Genomic and Precision Medicine Symposium: Model Systems: Preclinical to Phase I Bridge: Session 3, The Evolving Landscape of Regulation  /  Post-myocardial infarction fibrosis therapy: novel non-invasive approaches through the regulatory landscape
Logo

American Heart Association

  19
  0

Final ID:

Post-myocardial infarction fibrosis therapy: novel non-invasive approaches through the regulatory landscape

  • Radisic, Milica  ( UNIVERSITY OF TORONTO , Toronto , Ontario , Canada )
  • Ruiz-lozano, Pilar  ( Regen Cor Inc , Los Altos , California , United States )
    • Author Disclosures:
    Milica Radisic: DO have relevant financial relationships ; Consultant:Quthero Inc:Active (exists now) ; Royalties/Patent Beneficiary:Valo Health:Active (exists now) | Pilar Ruiz-Lozano: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Genomic and Precision Medicine Symposium: Model Systems: Preclinical to Phase I Bridge: Session 3, The Evolving Landscape of Regulation

Friday, 11/07/2025 , 04:00PM - 05:15PM

Cardiovascular Seminar

More abstracts on this topic:
Actualization of the FDA Reauthorization Act 2.0 for genotype-specific cardiovascular therapeutics

Adler Eric, Teerlink John, Helms Adam

Gene editing, replacement, and regulation targeting for cardiomyopathies

Hinson John, Rossano Joseph, Olson Eric, Mcnally Elizabeth

More abstracts from these authors:
Organ-on-a-chip Models of Cardiovascular Diseases

Radisic Milica

Repair damaged hearts by 3D printing and soft tissue engineering

Radisic Milica, Menasche Philippe

You have to be authorized to contact abstract author. Please, Login
Not Available